$CLDX News Stock leaders flex muscles 2:58 p.m. Feb.

New Post Public Reply Private Reply Replies (0) Message Board

Apr 24, 2014 at 11:55 AM

$CLDX News

Stock leaders flex muscles 2:58 p.m. Feb. 27, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
This tiny mutual fund is no. 1 for 2013 8:33 a.m. Jan. 7, 2014 - Suzanne McGee
Reading Wall Street’s tea leaves 3:44 p.m. Dec. 6, 2013 - The Trading Deck
Monthly jobs report triggers technical whipsaw 12:23 p.m. Sept. 6, 2013 - Michael Ashbaugh
Charting a market divergence 11:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Six stocks on the move 2:42 p.m. Aug. 21, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 11:10 a.m. July 3, 2013 - Michael Ashbaugh
S&P 500 hesitates at the breakdown point 11:14 a.m. June 26, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 3:22 p.m. June 12, 2013 - The Trading Deck
3 longs and 3 shorts to watch 2:33 p.m. April 17, 2013 - The Trading Deck
Hedge Funds have bought these stocks recently 3:04 p.m. April 12, 2013 - Insider Monkey
Hedge funds are bullish on these 5 stocks 8:38 a.m. Jan. 3, 2013 - Insider Monkey
Thursday’s top gaining and declining stocks 3:24 p.m. May 24, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 5:40 p.m. Feb. 24, 2012 - Kate Gibson
Celldex prices shares at 12% discount 12:26 p.m. Feb. 24, 2012 - MarketWatch.com
Rindopepimut ups brain cancer survival: Celdex 3:29 p.m. Nov. 21, 2011 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 3:33 p.m. May 18, 2011 - Kate Gibson
Celldex, Shire in drug-sector spotlight 1:35 p.m. May 18, 2011 - Val Brickates Kennedy
Celldex Therapeutics offer prices at 19% discount 9:48 a.m. May 18, 2011 - MarketWatch.com

Cramer's Mad Money - A Trader's Trash Is An Investor's Treasure (4/17/14) 6:08 a.m. April 18, 2014 - Seeking Alpha
Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock 9:52 a.m. April 17, 2014 - TheStreet.com
Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine 1:02 p.m. April 16, 2014 - benzinga.com
Hottest Healthcare Stocks Now – QCOR IMGN LCI PCRX 8:15 a.m. April 9, 2014 - InvestorPlace.com
Encouraging Pre-Clinical Data from Celldex - Analyst Blog 5:40 p.m. April 8, 2014 - Zacks.com
A Sharp Pullback In Celldex Could Be A Window Of Opportunity 3:41 p.m. April 8, 2014 - Seeking Alpha
8 Biotech Events To Anticipate This Year: Part Two 5:04 p.m. April 7, 2014 - Seeking Alpha
Jefferies Biotech Stocks to Buy With Breakthrough Drug Innovations 7:56 a.m. April 3, 2014 - 247WallSt.com
'Mad Money' Lightning Round: I Want You to Buy Costco 6:00 a.m. April 3, 2014 - TheStreet.com
Cramer's Lightning Round - This Is The Right Level For Costco (4/2/14) 5:50 a.m. April 3, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Hope Springs Eternal 8:24 p.m. April 2, 2014 - TheStreet.com
3 Biotech Stocks Trading The Wrong Direction In March 4:58 p.m. March 28, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – EXAS CLDX CLVS HSP 1:30 p.m. March 27, 2014 - InvestorPlace.com
These Stocks Are Getting Hit Hardest During March's Biotech 'Correction' 2:35 p.m. March 25, 2014 - TheStreet.com
Mid-Afternoon Market Update: Markets Recover Slightly As Healthcare Stocks Continue to Show Weakness 2:33 p.m. March 24, 2014 - benzinga.com
Mid-Day Market Update: NASDAQ Tumbles 1.65%; Nu Skin Shares Surge After AIC China Review Update 11:48 a.m. March 24, 2014 - benzinga.com
Mid-Morning Market Update: Markets Mostly Lower; ReneSola Swings To Q4 Profit 9:35 a.m. March 24, 2014 - benzinga.com
Northwest Bio's German Smokescreen Obscures DCVax Problems 2:44 p.m. March 11, 2014 - TheStreet.com
Celldex Therapeutics Is Shutting Down CDX-1135: What Does It Mean? 3:11 p.m. March 10, 2014 - Seeking Alpha
Oppenheimer Top Stocks to Buy as Bull Market Turns Five Years Old 9:26 a.m. March 10, 2014 - 247WallSt.com

Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine 2:01 p.m. April 16, 2014 - GlobeNewswire
Strategic Collaborations, Preclinical Studies Results, Patient Enrollment, Earnings Release Schedule, and Clinical Trial Initiations - Analyst Notes on Pacira, Celldex, Aegerion, Furiex, and Prothena 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Celldex Therapeutics Establishes Preclinical Proof of Concept for New Antibody Drug Conjugate CDX-014; Data presented at AACR 2014 4:01 p.m. April 7, 2014 - GlobeNewswire
Celldex Therapeutics to Present Antibody-Drug Conjugate CDX-014 Preclinical Proof of Concept Data at AACR 2014 8:04 a.m. April 3, 2014 - GlobeNewswire
Critical Alerts For Starbucks, Verizon Communications, Du Pont, Celldex Therapeutics, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. March 26, 2014 - PR Newswire - PRF
Technical Pointers - Top Gainers: Celldex Therapeutics, Sonus Networks, YOU On Demand Holdings, and CombiMatrix 9:12 a.m. March 18, 2014 - PR Newswire - PRF
Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy 9:03 a.m. March 3, 2014 - GlobeNewswire
Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call 2:30 p.m. Feb. 25, 2014 - GlobeNewswire
Critical Alerts For AT&T, Mastercard, Disney, Du Pont, and Celldex Therapeutics Released By InvestorsObserver 10:31 a.m. Feb. 12, 2014 - PR Newswire - PRF
Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference 12:00 p.m. Feb. 6, 2014 - GlobeNewswire
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 12:02 p.m. Jan. 21, 2014 - BusinessWire - BZX
Critical Alerts For Facebook, DirecTV, Du Pont, BIDU, and Celldex Released By InvestorsObserver 10:31 a.m. Jan. 9, 2014 - PR Newswire
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 9:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 9:00 a.m. Dec. 31, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 9:12 a.m. Dec. 19, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 9:00 a.m. Dec. 19, 2013 - PR Newswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 9:00 a.m. Dec. 13, 2013 - PR Newswire
New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis 9:00 a.m. Dec. 11, 2013 - PR Newswire
Celldex's CDX-301 in Combination with Mozobil(R) Increases Hematopoietic Stem Cell Mobilization and Results in Improved Transplantation of Mobilized Cells in Preclinical Studies; Results Presented at ASH 2013 9:30 a.m. Dec. 10, 2013 - GlobeNewswire
Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares 6:03 p.m. Dec. 9, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...